Perioperative Diagnosis and Risk Stratification in Obstructive Sleep Apnea

Abstract

Obstructive Sleep Apnea (OSA) is a prevalent disorder with significant perioperative implications, contributing to increased morbidity and mortality among surgical patients. Accurate preoperative diagnosis and risk stratification are crucial for optimizing perioperative outcomes. This review synthesizes current evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic modalities, and perioperative management of OSA, highlighting guideline recommendations and recent advances in the field. Practical, mechanism-based insights are provided to inform perioperative care and risk mitigation strategies for healthcare professionals.

Introduction

Obstructive Sleep Apnea (OSA) is a chronic disorder characterized by recurrent episodes of upper airway collapse during sleep, resulting in intermittent hypoxemia and sleep fragmentation. Its recognition as a significant perioperative risk factor has grown in recent years, owing to its association with adverse surgical outcomes such as respiratory complications, cardiovascular events, and prolonged hospital stays. Early identification and risk stratification are essential for tailoring perioperative management and ensuring patient safety. This review aims to provide a comprehensive overview of the current knowledge and clinical strategies relevant to perioperative diagnosis and risk stratification in OSA.

Epidemiology / Disease Burden

OSA affects approximately 9% to 38% of the general adult population, with higher prevalence observed in surgical cohorts, particularly among obese, male, and older patients. The disorder is underdiagnosed, with estimates suggesting that up to 80% of moderate-to-severe cases remain unrecognized, especially in perioperative settings. The high prevalence of OSA among surgical patients underscores the need for systematic screening and risk assessment. Disease burden is compounded by the association of OSA with hypertension, diabetes, coronary artery disease, heart failure, and cerebrovascular accidents, all of which increase perioperative risk and complicate postoperative recovery.

Pathophysiology

OSA results from anatomical and neuromuscular factors that predispose to upper airway collapse during sleep. Pharyngeal muscle hypotonia, increased pharyngeal soft tissue volume, and craniofacial abnormalities are common contributors. During sleep, reduced dilator muscle activity and negative intrathoracic pressure generated by inspiratory effort promote airway obstruction. The resulting cyclical hypoxemia triggers sympathetic surges, oxidative stress, and systemic inflammation, which exacerbate cardiovascular and metabolic comorbidities. In the perioperative context, anesthetic agents, sedatives, and opioids exacerbate airway collapsibility, further increasing the risk of postoperative airway compromise and hypoventilation.

Risk Factors

Major risk factors for OSA include obesity (BMI > 30 kg/m²), male sex, older age, craniofacial abnormalities, enlarged tonsils, and family history of OSA. Comorbidities such as hypertension, type 2 diabetes, and hypothyroidism also increase susceptibility. In the perioperative setting, additional risk factors include use of sedatives or opioids, upper airway surgeries, and supine positioning. Recognizing these risk factors is crucial for selecting patients requiring further evaluation and tailored perioperative strategies.

Clinical Features

OSA typically presents with loud snoring, witnessed apneas, nocturnal choking, and excessive daytime sleepiness. Other symptoms include morning headaches, impaired concentration, and mood disturbances. In the perioperative setting, undiagnosed OSA may manifest as difficult mask ventilation, hypoxemia, or hypercapnia postoperatively. The absence of classic symptoms does not exclude the diagnosis, especially in older adults or those with limited symptom awareness. Hence, systematic screening is recommended for high-risk patient populations.

Diagnosis

Polysomnography (PSG) remains the gold standard for diagnosing OSA, quantifying the Apnea-Hypopnea Index (AHI) to classify severity. Home sleep apnea testing (HSAT) offers a practical alternative for selected patients. Screening tools such as the STOP-BANG questionnaire, Berlin Questionnaire, and ASA checklist are widely used for perioperative risk stratification, with STOP-BANG favored for its sensitivity and ease of use. Preoperative identification of OSA facilitates planning for perioperative monitoring, airway management, and postoperative care. In resource-limited settings, clinical scoring systems may guide decision-making when diagnostic testing is unavailable.

Treatment & Management

Continuous Positive Airway Pressure (CPAP) is the first-line therapy for moderate-to-severe OSA and has demonstrated perioperative benefits, including reduced postoperative complications and shorter hospital stays. Alternative interventions include mandibular advancement devices and upper airway surgeries for selected patients. Perioperative strategies encompass optimization of comorbidities, minimizing sedative and opioid use, careful airway management, and enhanced postoperative monitoring. Patients with known or suspected OSA benefit from postoperative CPAP therapy and should be cared for in monitored settings when feasible. Multidisciplinary collaboration among anesthesiologists, surgeons, sleep specialists, and nursing staff is essential for individualized care planning.

Recent Advances / Emerging Therapies

Recent advances include the development of novel diagnostic algorithms integrating clinical risk scores with portable monitoring devices, improving efficiency and access to diagnosis. Hypoglossal nerve stimulation is an emerging therapy for selected patients with moderate-to-severe OSA intolerant of CPAP. Telemedicine approaches facilitate perioperative assessment and follow-up, enhancing adherence and long-term outcomes. Enhanced Recovery After Surgery (ERAS) protocols increasingly incorporate OSA-specific considerations, optimizing perioperative pathways. Ongoing research explores pharmacological agents targeting upper airway muscle tone and inflammation, with the potential to expand future treatment options.

Guideline Recommendations

Major societies, including the American Society of Anesthesiologists (ASA), recommend systematic screening for OSA in all patients undergoing moderate-to-high risk surgery. Preoperative risk stratification using validated questionnaires is endorsed to guide perioperative planning. CPAP therapy should be continued perioperatively in patients with established OSA, and postoperative monitoring is advised for those at elevated risk. Guidelines emphasize minimizing sedative and opioid use, optimizing comorbidities, and providing supplemental oxygen as appropriate. Coordination with sleep medicine specialists for perioperative optimization is strongly advocated.

Conclusion

OSA represents a significant perioperative risk factor demanding vigilant diagnosis and risk stratification. Advances in screening, diagnosis, and therapy enable targeted interventions that improve perioperative safety and outcomes. Integration of evidence-based guidelines and multidisciplinary collaboration is essential for optimizing care in surgical patients with known or suspected OSA. Ongoing research and emerging technologies hold promise for further enhancing perioperative management and reducing the burden of OSA-related complications.